David A. Siegel Ginkgo Bioworks Holdings, Inc. Transaction History

Two Sigma Advisers, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.28 - $1.16 $8.49 Million - $35.2 Million	30,312,507 Added 2680.05%	31,443,550 $10.4 Million
Q1 2024 May 15, 2024	BUY	$1.06 - $1.67 $400,786 - $631,427	378,100 Added 50.22%	1,131,043 $1.31 Million
Q4 2023 Feb 14, 2024	BUY	$1.26 - $1.79 $741,132 - $1.05 Million	588,200 Added 357.04%	752,943 $1.27 Million
Q3 2023 Nov 14, 2023	SELL	$1.61 - $2.54 $120,428 - $189,992	-74,800 Reduced 31.23%	164,743 $298,000
Q2 2023 Aug 14, 2023	BUY	$1.14 - $1.95 $24,281 - $41,535	21,300 Added 9.76%	239,543 $445,000
Q1 2023 May 15, 2023	BUY	$1.2 - $2.19 $166,920 - $304,629	139,100 Added 175.76%	218,243 $290,000
Q4 2022 Feb 14, 2023	BUY	$1.63 - $3.52 $129,003 - $278,583	79,143 New	79,143 $133,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $13B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.